| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |